Pharma Pulse 1/15/25: PBMs Mark Up Specialty Generic Drugs, Flurry of Acquisitions/Licensing Deals Amid JPM25 & more

News
Article

The latest news for pharma industry insiders.

Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Organizations including Gilead, Eli Lilly, and AbbVie announced a number of deals addressing inflammatory diseases, multiple myeloma, and other disease areas.

New FTC Report: PBMs Mark Up Specialty Generic Drugs

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and steer patients to their own pharmacies.

Moderna 2025 Revenue Guidance Below Wall Street’s Estimates

The biotech plans to deliver up to 10 product approvals over the next three years, while reducing costs across the business.

DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market

Market News Alerts Updates that DarioHealth Corp. is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers.

COPILOT Provider Support Services on LinkedIn

How do physician engagement and health-related social needs (HRSNs) impact burnout? A recent study highlighted in Pharmaceutical Commerce Magazine and published in JAMA explores this critical connection. Addressing HRSN challenges is essential for advancing health equity, but it may also increase the risk of physician burnout due to growing administrative demands.

Reducing these burdens is key to supporting physicians. For example, streamlining benefit verifications and resolving claims more efficiently can free up valuable time for providers to focus on patient care. Simplifying these processes not only helps mitigate burnout but also promotes health equity by improving access to therapy.

Empowering physicians to prioritize quality care is central to advancing patient outcomes.

Learn how our tailored HUB solutions support healthcare providers: www.cmcopilot.com

#dermatology #cardiology #oncology #hematology #patientaccess

https://lnkd.in/e7Pfk8m8

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs

© 2025 MJH Life Sciences

All rights reserved.